URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.
This bill is a non-binding resolution that urges Hawaii's State Director of Health to allow nebulized budesonide and nebulizer machines to be sold without a prescription. It cites international studies and health guidelines suggesting the medication can help treat respiratory conditions like COVID-19. The resolution requests that pharmacies and retailers provide written usage instructions to customers, but it does not change any laws or regulations. The bill does not require the Director of Health to take any action and has no legal effect beyond making a formal recommendation.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026
Last action Mar 18, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 18, 2026
Committee
Referred to HLT, CPC, referral sheet 19
lower
Mar 16, 2026
Introduced
Offered
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
David Alcos
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HCR 134
Scope: HI
Hi! I can help you understand HCR 134. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline